Hot off the Forge
-
“That mission has brought together an incredible group of scientists and partners who believe, as we do, that children with…
-
“Providing a new visual restoration treatment option for patients living with retinitis pigmentosa is central to our mission,” said Yusaku…
-
Under the partnership, Forge is providing Skylark with process development, current good manufacturing practice (cGMP) manufacturing, and analytical development services.
-
“At ASGCT, we’re proud to showcase how our FUEL™ platform is enabling more doses per batch, improving scalability for broader…
-
Epicrispr Biotechnologies and Forge announce a strategic partnership to support the development and manufacturing of EPI-321.
-
“Forge Biologics has set a powerful example of sustainability and scientific excellence advancing together.”
-
“The era of Progeria gene therapy has arrived. Our hope is that SamPro-2 will give children and young adults with…
-
Ascidian and Forge announce a strategic partnership to advance the development and manufacturing of ACDN-01, Ascidian’s lead retinal program for…
-
“Forge’s AAV-specific manufacturing expertise and platform technologies give us confidence in a smooth path forward in the development of AVST-101,”…
-
Fractyl Health will leverage Forge’s FUEL™ platform to manufacture AAV for Rejuva, Fractyl’s pancreatic gene therapy platform for patients with…
-
Oral and poster presentations will highlight data demonstrating the enhanced productivity, recovery, and consistent quality of Forge’s FUEL™ AAV manufacturing…
-
“We’re proud to support Affinia’s vision of bringing hope to patients affected by cardiomyopathy through their innovative gene therapy.”
ASGCT Breakthroughs in Cell + Gene Therapy
Bringing together professionals in cells and gene therapy to discuss the cutting-edge science and translational advances shaping the future of the field.